Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease. Zhang X, Wong GL, Yip TC, Tse YK, et al. Hepatology 2022;76:469-482.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang X, Wong GL, Yip TC, Tse YK, et al. Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease. Hepatology 2022;76:469-482.
PMID: 34939204